The provider administers a meningococcal recombinant lipoprotein vaccine intramuscularly to prevent the patient from getting a meningococcal disease such as Neisseria meningitides, as part of a two– or three–dose schedule. The vaccine is recommended for individuals 10 years old and older who are at risk for the disease.
For clinical responsibility, terminology, tips and additional info
start codify free trial.